Top 25 Smartest Companies To Buy According To Hedge Funds
Surviving in the modern day corporate world is not for the faint of heart. Business is a ruthless endeavor, and shareholder and investor interest reign supreme for each company.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 34,053 | $24,568,899 | -8% | 0.21% |
| 2. | Bailard Inc Thomas Bailard | 9,070 | $6,543,914 | +3% | 0.24% |
| 3. | Humankind Investments James Katz | 905 | $652,948 | -16% | 0.28% |
| 4. | Solstein Capital Nadine Terman And Jc Torres | 264 | $190,473 | -6% | 0.15% |
| 5. | AlphaCrest Capital Management Mika Toikka | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $487.01 | 2,557 | 23,880,537 | 2017-08-25 | Filing | ||
| $485.99 | 2,681 | 23,877,980 | 2017-08-25 | Filing | ||
| $485.28 | 5,723 | 23,875,299 | 2017-08-25 | Filing | ||
| $484.21 | 2,000 | 23,869,576 | 2017-08-25 | Filing | ||
| $482.87 | 4,485 | 23,867,576 | 2017-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $747.00 | 1 | Director | 1,247 | 2023-01-27 | Filing | |
| $747.14 | 3,070 | Director | 1,247 | 2023-01-06 | Filing | |
| $732.18 | 2 | Director | 19,182 | 2023-01-03 | Filing | |
| $731.59 | 12 | Director | 19,184 | 2023-01-03 | Filing | |
| $730.35 | 4 | Director | 19,196 | 2023-01-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 379,609 | $273,884,097 | 0.21% | |
| 2. | 118,417 | $85,436,682 | 0.73% | |
| 3. | 116,595 | $84,003,200 | 0.55% | |
| 4. | 110,103 | $80,814,501 | 0.03% | |
| 5. | 104,680 | $75,525,573 | 0.26% |
News See All
15 Most Undervalued Quality Stocks To Buy According To Hedge Funds
In this article, we discuss 15 most undervalued quality stocks to buy according to hedge funds.
12 Cheap Biotech Stocks To Buy
Some of the more famous names in the biotech space include companies like Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), BioNTech SE (NASDAQ:BNTX), and AbbVie Inc. (NYSE:ABBV).
15 Best S&P 500 Stocks That Don't Pay Dividends
In this article, we will be taking a look at the 15 best S&P 500 stocks that don't pay dividends.
5 Stocks That May Be Splitting Soon
AutoZone, Inc. (NYSE:AZO) is a leading retailer and one of the largest distributors of automotive parts and accessories in the United States.
10 Latest Earnings That Surprised Wall Street
In this article, we will take a look at the 10 latest earnings that surprised Wall Street.
Is Regeneron Pharmaceuticals (REGN) an Attractive Long-Term Stock?
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Is it a Good Decision to Add Regeneron Pharmaceuticals (REGN) to Your Portfolio?
Investment management company RGA Investment Advisors recently released its third-quarter 2022 investor letter. A copy of the same can be downloaded here.
10 Best Pharmaceutical Stocks to Buy According to Steven Boyd's Armistice Capital
In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd's Armistice Capital.
Billionaire Hedge Funds
